Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins

Journal of Neuroscience Methods

Volumn 157, Issue 2, 2006, Pages 208-217

  Mentis, George Z ^a   Gravell, Maneth ^a   Hamilton, Rebecca ^a   Shneider, Neil A ^a   O'Donovan, Michael J ^a   Schubert, Manfred ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Gene therapy; HIV 1; Motor neuron; Rabies virus glycoprotein

Indexed keywords

VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EYFP GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOTONEURON; MOTONEURON NUCLEUS; MOUSE; MUSCLE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RABIES VIRUS; RAT; REPORTER GENE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; TRANSGENE; VIRAL GENE THERAPY; VIRUS ENVELOPE; VIRUS TITRATION;

ANIMALS; GENE EXPRESSION; GENETIC VECTORS; GLYCOPROTEINS; HIV-1; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; MICE; MICROSCOPY, CONFOCAL; MOTOR NEURONS; MUSCLE, SKELETAL; RABIES VIRUS; RATS; TRANSDUCTION, GENETIC; TRANSFECTION; TRANSGENES; VIRAL PROTEINS;

EID: 33748439119     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.04.011     Document Type: Article

References (46)

1. Azzouz M., Kingsman S.M., and Mazarakis N.D. Lentiviral vectors for treating and modeling human CNS disorders. J Gene Med 6 (2004) 951-962
2. Bohn M.C. Motoneurons crave glial cell line-derived neurotrophic factor. Exp Neurol 190 (2004) 263-275
3. Bonnot A., Whelan P.J., Mentis G.Z., and O'Donovan M.J. Locomotor-like activity generated by the neonatal mouse spinal cord. Brain Res Brain Res Rev 40 (2002) 141-151
4. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27 (2004) 723-749
5. Coulon P., Derbin C., Kucera P., Lafay F., Prehaud C., and Flamand A. Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. J Virol 63 (1989) 3550-3554
6. Coulon P., Ternaux J.P., Flamand A., and Tuffereau C. An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro. J Virol 72 (1998) 273-278
7. Desmaris N., Bosch A., Salaun C., Petit C., Prevost M.C., Tordo N., et al. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol Ther 4 (2001) 149-156
8. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 72 (1998) 8463-8471
9. Ghadge G.D., Roos R.P., Kang U.J., Wollmann R., Fishman P.S., Kalynych A.M., et al. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther 2 (1995) 132-137
10. Graf W., Gerrits N., Yatim-Dhiba N., and Ugolini G. Mapping the oculomotor system: the power of transneuronal labelling with rabies virus. Eur J Neurosci 15 (2002) 1557-1562
11. Gubitz A.K., Feng W., and Dreyfuss G. The SMN complex. Exp Cell Res 296 (2004) 51-56
12. Guillot S., Azzouz M., Deglon N., Zurn A., and Aebischer P. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice. Neurobiol Dis 16 (2004) 139-149
13. Hottinger A.F., Azzouz M., Deglon N., Aebischer P., and Zurn A.D. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J Neurosci 20 (2000) 5587-5593
14. Humeau L.M., Binder G.K., Lu X., Slepushkin V., Merling R., Echeagaray P., et al. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV + infected patients grouped according to CD4 count and viral load. Mol Ther 9 (2004) 902-913
15. Ishihara A., Ohira Y., Tanaka M., Nishikawa W., Ishioka N., Higashibata A., et al. Cell body size and succinate dehydrogenase activity of spinal motoneurons innervating the soleus muscle in mice, rats, and cats. Neurochem Res 26 (2001) 1301-1304
16. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D., and Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301 (2003) 839-842
17. Keir S.D., Mitchell W.J., Feldman L.T., and Martin J.R. Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector. J Neurovirol 1 (1995) 259-267
18. Kelly R.M., and Strick P.L. Rabies as a transneuronal tracer of circuits in the central nervous system. J Neurosci Methods 103 (2000) 63-71
19. Lentz T.L., Burrage T.G., Smith A.L., and Tignor G.H. The acetylcholine receptor as a cellular receptor for rabies virus. Yale J Biol Med 56 (1983) 315-322
20. Lewis P., Fu Y., and Lentz T.L. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve 23 (2000) 720-730
21. Lu X., Humeau L., Slepushkin V., Binder G., Yu Q., Slepushkina T., et al. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol. J Gene Med 6 (2004) 963-973
22. Manilla P., Rebello T., Afable C., Lu X., Slepushkin V., Humeau L.M., et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 16 (2005) 17-25
23. Maric D., Maric I., Chang Y.H., and Barker J.L. Stereotypical physiological properties emerge during early neuronal and glial lineage development in the embryonic rat neocortex. Cereb Cortex 10 (2000) 729-747
24. Maric D., Maric I., Wen X., Fritschy J.M., Sieghart W., Barker J.L., et al. GABAA receptor subunit composition and functional properties of Cl- channels with differential sensitivity to zolpidem in embryonic rat hippocampal cells. J Neurosci 19 (1999) 4921-4937
25. Maric D., Millward J.M., Ballok D.A., Szechtman H., Denburg J.A., Barker J.L., et al. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Res 920 (2001) 183-193
26. Markusic D., Oude-Elferink R., Das A.T., Berkhout B., and Seppen J. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucl Acids Res 33 (2005) e63
27. Maskos U., Kissa K., St Cloment C., and Brulet P. Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice. Proc Natl Acad Sci USA 99 (2002) 10120-10125
28. Mazarakis N.D., Azzouz M., Rohll J.B., Ellard F.M., Wilkes F.J., Olsen A.L., et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 10 (2001) 2109-2121
29. Mochizuki H., Schwartz J.P., Tanaka K., Brady R.O., and Reiser J. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 72 (1998) 8873-8883
30. Morimoto K., Hooper D.C., Carbaugh H., Fu Z.F., Koprowski H., and Dietzschold B. Rabies virus quasispecies: implications for pathogenesis. Proc Natl Acad Sci USA 95 (1998) 3152-3156
31. Parveen Z., Mukhtar M., Rafi M., Wenger D.A., Siddiqui K.M., Siler C.A., et al. Cell-type-specific gene delivery into neuronal cells in vitro and in vivo. Virology 314 (2003) 74-83
32. Pastor A.M., Mentis G.Z., De La Cruz R.R., Diaz E., and Navarrete R. Increased electrotonic coupling in spinal motoneurons after transient botulinum neurotoxin paralysis in the neonatal rat. J Neurophysiol 89 (2003) 793-805
33. Pfeifer A., Brandon E.P., Kootstra N., Gage F.H., and Verma I.M. Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci USA 98 (2001) 11450-11455
34. Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 7 (2000) 910-913
35. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 344 (2001) 1688-1700
36. Schnell M.J., Tan G.S., and Dietzschold B. The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines. J Neurovirol 11 (2005) 76-81
37. Sena-Esteves M., Tebbets J.C., Steffens S., Crombleholme T., and Flake A.W. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 122 (2004) 131-139
38. Shankar V., Dietzschold B., and Koprowski H. Direct entry of rabies virus into the central nervous system without prior local replication. J Virol 65 (1991) 2736-2738
39. Thoulouze M.I., Lafage M., Schachner M., Hartmann U., Cremer H., and Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. J Virol 72 (1998) 7181-7190
40. Tissenbaum H.A., and Parry D.J. The effect of partial denervation of tibialis anterior (TA) muscle on the number and sizes of motorneurons in TA motornucleus of normal and dystrophic (C57BL dy2j/dy2j) mice. Can J Physiol Pharmacol 69 (1991) 1769-1773
41. Tsiang H., Lycke E., Ceccaldi P.E., Ermine A., and Hirardot X. The anterograde transport of rabies virus in rat sensory dorsal root ganglia neurons. J Gen Virol 70 Pt 8 (1989) 2075-2085
42. Wiznerowicz M., and Trono D. Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol 23 (2005) 42-47
43. Zhang B., Metharom P., Jullie H., Ellem K.A., Cleghorn G., West M.J., et al. The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events. Genet Vaccines Ther 2 (2004) 6
44. Zheng Y.L., Kesavapany S., Gravell M., Hamilton R.S., Schubert M., Amin N., et al. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J 24 (2005) 209-220
45. Zhou L., Baumgartner B.J., Hill-Felberg S.J., McGowen L.R., and Shine H.D. Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci 23 (2003) 1424-1431
46. Zufferey R., and Trono D. Production of high-titer lentiviral vectors. Current protocols in neuroscience 4.21 (2000), John Wiley and Sons Inc. p. 1-12